Julian Ritchey

As Head of US Vaccine Public Affairs and Patient Advocacy for Sanofi, Julian drives sustainable public health improvement through education and collaboration to achieve corporate growth objectives.

Focus areas include:
• US Immunization Policy - development, coordination, and communication with stakeholders including the Centers for Disease Control and Prevention (CDC), state governments, advocacy organizations, and the Biotechnology Industry Organization (BIO) trade group.
• Patient Advocacy – foster relations with a variety of patient and provider organization to enable the joint identification, creation, and implementation of initiatives that engage vaccine stakeholders, grow disease awareness, and strengthen the connections between immunization and patient-centered health measures.
• Strategic Initiatives – interface with and optimize relationships between Sanofi Pasteur and external partners, including the Bill and Melinda Gates Foundation, BIO industry trade organization, LifeSciences PA, and Team PA in order to advance a variety of collaborative goals on a global, national, and state levels.

Over the course of more than 25 years with Sanofi, Julian has held positions of increasing responsibility within the Commercial Operations organization across both Sales and Marketing. In US Marketing, roles have included responsibility for the launch and promotion of flagship brands such as Daptacel, Menactra, Pentacel. Globally he led the Pneumococcal and Meningitis vaccines franchises, and more recently co-led global commercial preparations for a late-stage vaccine candidate. He established the US Customer Marketing organization, ran the US New Products group, and headed the Medical Communications group where he oversaw the national Medical Science Liaison team and development of opinion leader relationships.